SO
ZBIO

STRS Ohio’s Zenas BioPharma ZBIO Stock Holding History

STRS Ohio’s Portfolio ZBIO Stock Details ZBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,800
Closed -$54.7K – 2358
2026
Q1 		$54.7K Hold
2,800
– – ﹤0.01% 1918
2025
Q4 		$102K Hold
2,800
– – ﹤0.01% 1812
2025
Q3 		$62.2K Hold
2,800
– – ﹤0.01% 1961
2025
Q2 		$27.1K Hold
2,800
– – ﹤0.01% 2113
2025
Q1 		$22.1K Hold
2,800
– – ﹤0.01% 1846
2024
Q4 		$22.9K Buy
+2,800
New +$43.7K ﹤0.01% 1808

Other funds holding ZBIO

IGAM
iA Global Asset Management Quebec, Quebec, Canada $8.42B AUM 47.61% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

STRS Ohio's ZBIO Position: Q2 2026 in Review

STRS Ohio sold out of Zenas BioPharma (ZBIO) in Q2 2026, closing a stake of 2,800 shares — an estimated $54.7K sold.

STRS Ohio first reported a position in ZBIO in Q4 2024 and held it in 6 quarters. The position peaked at $102K in Q4 2025. 17 funds tracked by Wall St. Rank hold ZBIO as of Q2 2026.

  • STRS Ohio reported no remaining Zenas BioPharma position as of Q2 2026 after selling out during the quarter.
  • STRS Ohio sold 2,800 Zenas BioPharma shares in Q2 2026, an estimated $54.7K.
  • STRS Ohio first reported a position in Zenas BioPharma in Q4 2024 and held it in 6 quarters.
  • STRS Ohio's Zenas BioPharma position peaked at $102K in Q4 2025.
  • 17 funds tracked by Wall St. Rank held Zenas BioPharma as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.